DURHAM, N.C.--(BUSINESS WIRE)--BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the acquisition of IPM ...
Highly complementary transaction strengthens BioAgilytix's ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of ...
HAMBURG, GERMANY, May 8, 2023/EINPresswire.com/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical lab, today announced the expansion and GMP ...
FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for Friedreich ataxia. DURHAM, NC, UNITED ...
RESEARCH TRIANGLE PARK – BioAgilytix, one of North Carolina’s fastest-growing home-grown life sciences companies, is adding 878 new employees with a $61.5 million investment in its global Durham ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results